In the seventh episode of the GHAPP & RhAPP biosimilar podcast series host Amanda Mixon, PA-C, and guest Audrey Gibson, PA-C discuss the interplay between managed care and biosimilars.
The learning objectives for this episode are to:
- Discuss managed care implications for biosimilars reaching the market
- Identify the benefits of biosimilars in managed care
- Formulate strategies managed care professionals can employ to establish clinical pathways and increase biosimilar uptake in practice
Please take our evaluation regarding this podcast here: https://www.ghapp.org/biosimilars-podcast-eval
You Might Like
